Calloway Labs is one of the nation’s fastest growing clinical toxicology laboratories. We specialize in urine drug testing to address critical challenges facing today’s medical professionals in the treatment of chronic pain. Our Pain Care Protocols are designed to improve patient care while limiting physician liability.
Calloway invests in the latest technology and employs highly trained personnel to provide a portfolio of drug testing protocols tailored for each practice’s needs. As an industry leader, we were to first to introduce buprenorphine, tramadol, and oxycodone testing. We were also the first to provide test results over a HIPAA-compliant web site and integrate a medical review process for non-forensic toxicology review. Calloway’s laser technology represents the first use of lasers for confirmation of drug tests.
Obsessively customer-focused, Calloway's reputation has been built on a foundation of rapid turnaround, accurate results, and exceptional client support. All of Calloway's protocols are custom-tailored to meet each physician’s needs and are subjected to rigorous quality standards.
Calloway is a CLIA-certified laboratory and holds a Clinical Laboratory License issued by the Commonwealth of Massachusetts. We are further qualified to serve the needs of physicians in the lower 48 states.
The company’s headquarters, including its laboratory, is located outside Boston, Massachusetts.
“Urine Drug Testing can be
a valuable tool in the pain management setting to help monitor compliance to an agreed-upon treatment plan.”
(A Clinical Guide to Urine Drug Testing, UMDNJ – Center for Continuing Education and Outreach, May 2008)
